Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
In October 1999, we emailed the corresponding authors of the last 100 original articles published in the BMJ, Lancet, and New England Journal of Medicine.
The email read:
"PubMed Central, NIH's web based repository of original research in the life sciences, will 'go live' in January. It will provide free access to articles that existing journals, new journals, and reputable scientific organisations have submitted to it.
Despite its potential benefits to the scientific community, the initiative has thrown many existing journals into turmoil as they wonder how to compensate for lost subscriptions.
At the BMJ we want to hear what authors have to say about the proposal before deciding our policy.
Could we therefore have your response to a single question:
When it comes to deciding where to submit your articles, how important will a journal's participation in PubMed Central be?
Very important
Important
Neither important nor unimportant
Unimportant
Very unimportant
As well as helping us, your response may also inform the policies of journals other than the BMJ."
Results
Overall response rate: 70/300 (23%)
BMJ - 100 email sent/38 replies
Very important - 11
Important - 11
Neither important nor unimportant - 9
Unimportant - 5
Very unimportant - 2
Lancet - 100 email sent/15 replies
Very important - 6
Important - 2
Neither important nor unimportant - 6
Unimportant - 1
Very unimportant - 0
NEJM - 100 email sent/17 replies
Very important - 4
Important - 4
Neither important nor unimportant - 3
Unimportant 2
Very unimportant - 4
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.